awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38193896-00E1955B-BD7C-447A-9F7D-18E424B8F705
Q38193896-00E1955B-BD7C-447A-9F7D-18E424B8F705
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38193896-00E1955B-BD7C-447A-9F7D-18E424B8F705
Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β₃-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB).
P2860
Q38193896-00E1955B-BD7C-447A-9F7D-18E424B8F705
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38193896-00E1955B-BD7C-447A-9F7D-18E424B8F705
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c467280afbc451e205fa453441dcb844935a0972
P2860
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.